This annual award recognizes cutting-edge innovation from exhibitors at the AOSSM Annual Meeting in the field of orthopaedic sports medicine.
Eligibility and Guidelines:
· All exhibitors at the 2020 AOSSM Annual Meeting are eligible to submit entries for this award. There is no limit to the number of entries for exhibitors.
· Devices, procedures, techniques, materials, etc. introduced since the previous AOSSM Annual Meeting. This includes modifications to existing concepts that substantially improves outcomes in orthopaedic sports medicine.
· Must be on display in the Exhibit Hall during the 2020 AOSSM Annual Meeting.
· Supporting information must be made available for the judges to inform their scoring and deliberations.
· Supporting information may include, but is not limited to, product literature and statistics, podium and/or poster presentations about the product or similar data and information.
· At the judges' discretion, up to three winners will be selected, but no more than three winners at the 2020 AOSSM Annual Meeting.
To apply, exhibitors must complete the online application by May 15, 2020. Applications open April 1, 2020.
Judging will begin with a review of all submitted entries from exhibitors at the 2020 AOSSM Annual Meeting. Finalists will be selected from this initial pool of applications and exhibitors notified by June 30, 2020 of the disposition of their application.
The judging panel, made up of AOSSM members, will visit the selected finalist’s exhibition space in the Exhibit Hall at specified times and meet with exhibitor representatives to review the entry and collect supporting materials. Finalists must ensure AT LEAST ONE person at the booth during the judging time frame can discuss the product with the judges.
All finalists must agree to participate in the competition and pre-accept the designation before being officially awarded.
Winners will be notified at their exhibit space followed shortly with an announcement in the exhibit hall.
Scoring Criteria and System
The judging panel’s decision will be based on the following criteria (in no order of significance):
· Creativity and Innovation – the exhibited concept reflects a novel discovery in musculoskeletal science coupled with the creation and evaluation using appropriate science.
· Long term applicability in practice – the exhibited concept is likely to sustain a lasting impact in the field and/or goes beyond an incremental improvement to existing knowledge.
· Potential impact on clinical practice – the exhibited concept is practical, likely to see substantial uptake in the field, and sustained use by practitioners.
· Improves standard of care – the exhibited concept compares well to an existing gold standard in the field or creates a new paradigm for patient care
· Benefits vs. Harms and/or effectiveness – the exhibited product is safe and minimizes risk to patients while displaying positive outcomes.